References
Abou-Donia, M. B. 1981. Organophosphorous ester-induced delayed neurotoxicity. Annu. Rev. Pharmacol. Toxicol. 21:511–548.
ACGIH (American Conference of Governmental Industrial Hygienists). 1982. Threshold Limit Values for Chemical Substances and Physical Agents in the Workroom Environment with Intended Changes for 1982. Cincinnati, OH: American Conference of Governmental Industrial Hygienists Publications Office.
ACS (American Chemical Society), Committee on Enviromental Improvement and Subcommittee on Environmental Analytical Chemistry. 1980. Guidelines for data acquisition and data quality evaluation in environmental chemistry. Anal. Chem. 52:2242–2249.
Adams, J. 1986. Methods in behavioral teratology. Pp. 67–92 in Handbook of Behavioral Teratology , E. P. Riley and C. V. Vorhees, eds. New York: Plenum.
Aghajanian, G. K. 1972. LSD and CNS transmission. Annu. Rev. Pharmacol. 12:157–168.
Aldridge, W. N. 1990. An assessment of the toxicological properties of pyrethroids and their neurotoxicity. Crit. Rev. Toxicol. 21:89–104.
Aleu, F. P., R. Katzman, and R. D. Terry. 1963. Fine structure and electrolyte analysis of cerebral edema induced by alkyltin intoxication. J. Neuropathol. Exp. Neurol. 22:403–413.
Allen, N., J. R. Mendell, J. Billmaier, R. E. Fontaine, and J. O'Neill. 1975. Toxic polyneuropathy due to methyl n-butyl ketone. Arch. Neurol. 32:209–218.
Altenkirch, H., S. Stoltenburg-Didinger, and C. Koeppel. 1988. The neurotoxicological aspects of the toxic oil syndrome (TOS) in Spain. Toxicol. 49:25–34.
Amdur, M.O., J. Doull, and C.D. Klaassen, eds. 1991. Casarett and Doull's Toxicology: The Basic Science of Poisons , 4th ed. New York: Pergamon Press. 1033 pp.
Anger, W. K. 1984. Neurobehavioral testing of chemicals: Impact on recommended standards. Neurobehav. Toxicol. Teratol. 6:147–153.
Anger, W. K. 1985. Neurobehavioral tests used in NIOSH-supported worksite studies, 1973–1983. Neurobehav. Toxicol. Teratol. 7:359–368.
Anger, W. K. 1986. Workplace exposures. Pp. 331–347 in Neurobehavioral Toxicology, Z. Annau, ed. Baltimore, Md.:Johns Hopkins University Press.
Anger, W. K. 1989. Human neurobehavioral toxicology testing: Current perspectives. Toxicol. Ind. Health 5:165–180.
Anger, W. K. 1990. Worksite behavioral research: Results, sensitive methods, test batteries, and the transition from laboratory data to human health. Neurotoxicology 4:627–718.
Anger, W. K., and B. L. Johnson. 1985. Chemicals affecting behavior. Pp. 51–148 in Neurotoxicity of Industrial and Commercial Chemicals, Vol. 1, J. L. O'Donoghue, ed. Boca Raton, Fla.: CRC Press.
Annau, Z., and C. U. Eccles. 1986. Prenatal exposure. Pp. 153–169 in Neurobehavioral Toxicology, Z. Annau, ed. Baltimore: The Johns Hopkins University Press.
Anthony, D.C., and D.G. Graham. 1991. Toxic responses of the nervous system. Pp. 407–429 in Cassarett and Doull's Toxicology: The Basic Science of Poisons, 4th ed., M.O. Amdur, J. Doull, and C.D. Klaassen, eds. New York: Pergamon Press.
Anthony, D. C., K. Boekelheide, and D. G. Graham. 1983a. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. I. Accelerated clinical neuropathy is accompanied by more proximal axonal swellings. Toxicol. Appl. Pharmacol. 71:362–371.
Anthony, D. C., K. Boekelheide, C. W. Anderson, and D. G. Graham. 1983b. The effect of 3,4-dimethyl substitution on the neurotoxicity of 2,5-hexanedione. II. Dimethyl substitution accelerates pyrrole formation and protein crosslinking. Toxicol. Appl. Pharmacol. 71:372–382.
Arezzo, J. C., and H. H. Schaumburg. 1980. The use of OptaconR as a screening device: A new technique for detecting sensory loss in individuals exposed to neurotoxins . J. Occup. Med. 22:461–464.
Arezzo, J. C., and H. H. Schaumburg. 1989. Screening for neurotoxic disease in humans. J. Am. Coll. Toxicol. 8:147–155.
Arezzo, J. C., H. H. Schaumburg, and C. A. Petersen. 1983. Rapid screening for peripheral neuropathy: A field study with the Optacon. Neurology 33:626–629.
ASPH (Association of Schools of Public Health). 1988. A proposed national strategy for the prevention of neurotoxic disorders. Pp. 31–48 in Proposed National Strategies for the Prevention of Leading Work-Related Diseases and Injuries, Part 2. Association of Schools of Public Health, Washington, D.C.
Baker, E. L. 1989. Sentinel event notification system for occupational risks (SENSOR): The concept. Am. J. Public Health 79(Suppl.):18–20.
Baker, E. L., R. E. Letz, A. T. Fidler, S. Shalat, D. Plantamura, and M. Lyndon. 1985. A computer-based neurobehavioral evaluation system for occupational and environmental epidemiology: Methodology and validation studies. Neurobehav. Toxicol. Teratol. 7:369–377.
Barbeau, A., M. Roy, G. Bernier, G. Campanella, and S. Paris. 1987. Ecogenetics of Parkinson's disease: Prevalence and environmental aspects in rural areas. Can. J. Neurol. Sci. 14:36–41.
Battistin, L., and F. Gerstenbrand, eds. 1986. PET and NMR: New Perspectives in Neuroimaging and in Clinical Neurochemistry. New York: Alan R. Liss. 518 pp.
Bellare, R. A. 1967. Studies in Manganese Poisoning. University of Bombay, India. Ph.D. Dissertation.
Bellinger, D., A. Leviton, C. Waternaux, H. Needleman, and M. Rabinowitz. 1987a. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N. Eng. J. Med. 316:1037–1043.
Bellinger, D., J. Sloman, A. Leviton, C. Waternaux, H. Needleman. 1987b. Lowlevel lead exposure and child development: Assessment at age 5 of a cohort followed from birth. Proceedings of the International Conference on Heavy Metals in the Environment, Vol. 1. Edin-
burgh: CEP Consultants. (Abstr.)
Belongia E. A., C. W. Hedberg, G. J. Gleich, K. E. White, A. N. Mayeno, D. A. Loegering, S. L. Dunnette, P. L. Pirie, K. L. MacDonald, and M. T. Osterholm. 1990. An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N. Engl. J. Med. 323(6):357–365.
Betz, A. L., G. W. Goldstein, and R. Katzman. 1989. Blood-brain-cerebrospinal fluid barriers. Pp. 591–608 in Basic Neurochemistry, 4th ed., G. Siegel, B. Agranoff, R. W. Albers, and P. Molinoff, eds. New York: Raven Press.
Bhattacharyya, T. K., and V. S. Dayal. 1984. Ototoxicity and noise-drug interaction. J. Otolaryngol. 13:361–366.
Bidstrup, P. L. 1964. Toxicity of Mercury and its Compounds. Amsterdam: Elsevier Scientific Publishing Company.
Billmaier, D., H. T. Yee, N. Allen, B. Craft, N. Williams, S. Epstein, and R. Fontaine. 1974. Peripheral neuropathy in a coated fabrics plant. J. Occup. Med. 16:665–671.
Blair, V. W., A. R. Hollenbeck, R. F. Smith, and J. W. Scanlon. 1984. Neonatal preference for visual patterns: Modification by prenatal anesthetic exposure? Dev. Med. Child. Neurol. 26:476–483.
Boettcher, F. A., D. Henderson, M. A. Gratton, R. W. Danielson, and C. D. Byrne. 1987. Synergistic interactions of noise and other ototraumatic agents. Ear Hear. 8:192–212.
Bogo, V., T. A. Hill, and R. W. Young. 1981. Comparison of accelerod and roto-rod sensitivity in detecting ethanol-and acrylamide-induced performance decrement in rats: Review of experimental considerations of rotating systems. Neurotoxicology 2:765–787.
Boylan, J. J., J. L. Egle, P. S. Guzelian. 1978. Cholestyramine: Use as a new therapeutic approach for chlordecone (Kepone) poisoning. Science 199:893–895.
Broadwell, R. D. 1989. Transcytosis of macromolecules through the blood-brain barrier: A cell biological perspective and critical appraisal. Acta Neuropathol. (Berl.) 79:117–128.
Brydon, J. E., V. H. Morgenroth, III, A. Smith, and R. Visser. 1990. OECD's Work on Investigation of High Production Volume Chemicals. EXHVA/90.163/2.5. Paris: OECD (Organisation for Economic Co-operation and Development). 5 February 1990. 17 pp.
Buchthal, F., and R. Behse. 1979. Electro-physiology and nerve biopsy in men exposed to lead. Br. J. Ind. Med. 36:135–147.
Buelke-Sam, J., C. A. Kimmel, J. Adams, C. J. Nelson, C. V. Vorhees, D. C. Wright, V. St. Omer, B. A. Korol, R. E. Butcher, M. A. Geyer, J. F. Holson, C. L. Kutscher, and M. J. Wayner. 1985. Collaborative behavioral teratology study: Results. Neurobehav. Toxicol. Teratol. 7:591–624.
Butcher, R. E., and C. V. Vorhees. 1979. A preliminary test battery for investigation of the behavioral teratology of selected psychotropic drugs. Neurobehav. Toxicol. 1(Suppl. 1):207–212.
Cabe, P. A., and H. A. Tilson. 1978. The hindlimb extensor response: A method for assessing motor dysfunction in rats. Pharmacol. Biochem. Behav. 9:133–136.
Calne, D. B., and J. W. Langston. 1983. Aetiology of Parkinson's disease. Lancet 2(8365–66):1457–1459.
Calne, D. B., J. W. Langston, W. R. W. Martin, A. J. Stoessl, T. J. Ruth, M. J. Adam, B. D. Pate, and M. Schulzer. 1985. Positron emission tomography after MPTP: Observations relating to the cause of Parkinson's disease. Nature 317:246–248.
Calne, D. B., A. Eisen, E. McGeer, and P. Spencer. 1986. Alzheimer's disease, Parkinson's disease, and motoneurone disease: A biotrophic interaction between ageing and environment? Lancet II(8515):1067–1070.
Cannon, S. B., J. M. Veazey, Jr., R. S. Jackson, V. W. Burse, C. Hayes, W. E. Straub, P. J. Landrigan, and J. A. Liddle. 1978. Epidemic kepone poisoning in chemical workers. Am. J. Epidemiol. 107:529–537.
Cassells, D. A. K., and E. C. Dodds. 1946. Tetra-ethyl lead poisoning. Brit. Med. J. 2:4479–4483.
Cavanagh, J. B. 1964. The significance of the ''dying-back'' process in experimental and human neurological disease. Int. Rev. Exp. Path. 3:219–267.
Cavanagh, J. B., and R. J. Bennetts. 1981. On the pattern of changes in the rat nervous system produced by 2,5-hexanediol: A topographical study by light microscopy. Brain 104:297–318.
Cavanagh, J. B., and F. C.-K. Chen. 1971. The effects of methyl-mercury-dicyan-diamide on the peripheral nerves and spinal cord of rats. Acta Neuropathol. (Berlin) 19:208–215.
Cavanagh, J. B., and J. M. Jacobs. 1964. Some quantitative aspects of diphtheriticn neuropathy. Brit. J. Exp. Path. 45:309–327.
CDC (Centers for Disease Control, U. S. Public Health Service). 1978. Acute and possible long-term effects of 1,3 dichloro-propene—California. MMWR (Morbidity and Mortality Weekly Report) Feb. 17:50,55. U.S. Department of Health and Human Services. Washington, D.C.: U.S. Government Printing Office.
Chernoff, N., and Kavlock, R. J. 1982. An in vivo teratology screen utilizing pregnant mice. J. Toxicol. Environ. Health 10:541–550.
Chiba S., and K. Ando. 1976. Effects of chronic administration of kanamycin on conditioned suppression to auditory stimulus in rats. Jpn. J. Pharmacol. 26:419–426.
Cho, E-S., P. S. Spencer, and B. S. Jortner. 1980. Doxorubicin. Pp. 430–439 in Experimental and Clinical Neurotoxicology, P. S. Spencer and H. H. Schaumburg, eds. Baltimore: Williams & Wilkins.
Cohrssen, J. J., and V. T. Covello. 1989. Risk Analysis: A Guide to Principles and Methods for Analyzing Health and Environmental Risks. United States Council on Environmental Quality, Executive Office of the President. Available from NTIS as PB 89-137772.
Committee on Biological Markers of the National Research Council 1987. Biological markers in environmental health research. Environ. Health Perspect. 74:3–9.
Cook, D. G., S. Fahn, and K. A. Brait. 1974. Chronic manganese intoxication. Arch. Neurol. 30:59–71.
Cossa, P., J. Duplay, L. Fishgold, L. Arfel-Capdeville, M. Passouant, and J. Radermecker. 1959. Encephalopathies toxiques au Stalinon: Aspects anatomocliniques et electroencephalographiques. Acta Neurol. Psychiatrica Belg. 59:281–303.
Couri, D., and J. P. Nachtman. 1979. Biochemical and biophysical studies of 2,5-hexanedione neuropathy. Neurotoxicology 1:269–283.
Cranmer, J. M., and L. Goldberg, eds. 1986. Proceedings of the workshop on neurobehavioral effects of solvents. Neurotoxicology 7:1–123.
Crofton, K. M., and L. P. Sheets. 1989. Evaluation of sensory system function using reflex modification of the startle response. J. Amer. Coll. Toxicol. 8:199–212.
Crouch, E. A., and R. Wilson. 1987. Risk assessment and comparisons: An introduction. Science: 236:267–270.
Crump, K. S. 1984. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 4:854–871.
Cushner, I. M. 1981. Maternal behavior and perinatal risks: Alcohol, smoking, and drugs. Ann. Rev. Pub. Health 2:201–218.
Damstra, T., and S. C. Bondy. 1980. The current status and future of biochemical
assays for neurotoxicity. Pp. 820–833 in Experimental and Clinical Neurotoxicology, P. S. Spencer and H. H. Schaumburg, eds. Baltimore: Williams & Wilkens.
Davies, P. W. 1968. The action potential. Pp. 1094–1120 in Medical Physiology, Vol. II, 12th ed., V. B. Mountcastle, ed. St. Louis: C. V. Mosby.
DeCaprio, A. P. 1985. Molecular mechanisms of diketone neurotoxicity. Chem. Biol. Interact. 54:257–270.
DeCaprio, A. P., E. J. Olajos, and P. Weber. 1982. Covalent binding of a neurotoxic n-hexane metabolite: Conversion of primary amines to substituted pyrrole adducts by 2,5-hexanedione. Toxicol. Appl. Pharmacol. 65:440–450.
DeCaprio, A. P., R. G. Briggs, S. J. Jackowski, and J. C. S. Kim. 1988. Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and per-deuterio-2,5-hexanedione in the rat. Toxicol. Appl. Pharmacol. 92:75–85.
Denny-Brown, D. 1947. Neurological conditions resulting from prolonged and severe dietary restriction. Medicine 26:41–113.
Dick, R. B., and B. L. Johnson. 1986. Human experimental studies. Pp. 348–387 in Neurobehavioral Toxicology, Z. Annau, ed. Baltimore: The Johns Hopkins University Press.
Diener, R. M. 1987. Behavioral toxicology: Current industrial viewpoint. J. Am. Coll. Toxicol. 4:427–432.
Doull, J. 1980. Factors influencing toxicology. Pp. 70–83 in Casarett and Doull's Toxicology: Basic Science of Poisons, 2nd ed., J. Doull, C. D. Klaassen, and M. O. Amdur, eds. New York: Macmillan.
Dourson, M. L., and J. F. Stara. 1983. Regulatory history and experimental support of uncertainty (safety) factors. Regul. Toxicol. Pharmacol. 3:224–238.
Eckerman, D. A., J. B. Carroll, D. Foree, C. M. Gullion, M. Lansman, E. R. Long, M. B. Waller, and T. S. Wallsten. 1985. An approach to brief field testing for neurotoxicity. Neurobehav. Toxicol. Teratol. 7:387–393.
Edelman, G. M. 1987. Neural Darwinism: The Theory of Neuronal Group Selection. New York: Basic Books. 371 pp.
Edwards, P. M., and V. H. Parker. 1977. A simple, sensitive and objective method for early assessment of acrylamide neuropathy in rats. Toxicol. Appl. Pharmacol. 40:589–591.
EPA (U.S. Environmental Protection Agency). 1985. Toxic Substances Control Act Test Guidelines. Final Rules. 40 CFR Part 798, Subpart 798.6050. FR 50(188):39458–39460.
Evans, H. L. 1989. Behaviors in the home cage reveal neurotoxicity: Recent findings and proposals for the future. J. Am. Coll. Toxicol. 8:35–52.
Evans, H. L., V. G. Laties, and B. Weiss. 1975. Behavioral effects of mercury and methylmercury. Fed. Proc. 34:1858–1867.
FDA (U.S. Food and Drug Administration). 1988. Good laboratory practice for nonclinical laboratory studies. Code of Federal Regulations, Title 21, Chap. 1, Pt. 58. Washington, D.C.: U.S. Government Printing Office.
Fechter, L. D., and J. S. Young. 1983. Discrimination of auditory from nonauditory toxicity by reflex modulation audiometry. Effects of triethyltin. Toxicol. Appl. Pharmacol. 70:216–227.
Federal Register. 1978. Pesticide Programs. Proposed Guidelines for Registering Pesticides in the U. S.; Hazard Evaluation: Humans and Domestic Animals . FR 43(163):37362. Washington, D.C.: U.S. Government Printing Office. August 22.
Federal Register. 1985. Toxic Substances Control Act Test Guidelines: Final Rule, Part II. Vol. FR 50(188):39458–39470. Washington, D.C.: U.S. Government Printing Office.
Fisher, F. 1980. Neurotoxicology and gov-
ernmental regulation of chemicals in the United States. Pp. 874–882 in Experimental and Clinical Neurotoxicology, P. S. Spencer and H. H. Schaumburg, eds. Baltimore, Md.: Williams & Wilkins.
Foege, W. H., R. C. Hogan, and L. H. Newton. 1976. Surveillance projects for selected diseases. Int. J. Epidemiol. 5:29–37.
Fortemps, E., G. Amand, A. Bomboir, R. Lauwerys, and E. C. Laterre. 1978. Trimethyltin poisoning: A report of two cases. Int. Arch. Occup. Environ. Health 41:1–6.
Fowler, S. C. 1987. Force and duration of operant responses as dependent variables in behavioral pharmacology. Pp. 83–127 in Neurobehavioral Pharmacology, Vol. 6, Advances in Behavioral Pharmacology, T. Thompson, P. B. Dews, and J. E. Barrett, eds. New York: Erlbaum Press.
Fowler, B. A., and E. K. Silbergeld. 1989. Occupational diseases—new workforces, new workplaces. Ann. N. Y. Acad. Sci. 572:46–54.
Frazier, J. M. 1990. Validation of in vitro models. J. Am. Coll. Toxicol. 9:355–359.
French, L. R., L. M. Schuman, J. A. Mortimer, J. T. Hutton, R. A. Boatman, and B. Christians. 1985. Am. J. Epidemiol. 121:414–421.
Friberg, L. 1977. Toxicology of Metals, Vol. 2. Permanent Commission and International Association of Occupational Health in cooperation with the Swedish Environmental Protection Board and the Karolinska Institute. EPA-600/1-77-022. Report available through the NTIS as PB-268–324.
Friedland, R. P., W. J. Jagust, R. H. Huesman, E. Koss, B. Knittel, C. A. Mathis, B. A. Ober, B. M. Mazoyer, and T. F. Butinger. 1989. Regional cerebral glucose transport and utilization in Alzheimer's disease. Neurology 39:1427–1434.
Friedlander, T. R., and F. T. Hearne. 1980. Epidemiologic considerations in studying neurotoxic disorders. Pp. 650–662 in Experimental and Clinical Neurotoxicology, P. S. Spencer and H. H. Schaumburg, eds. Baltimore: Williams & Wilkins.
Fromm, C., and E.V. Evarts. 1981. Relation of size and activity of motor cortex pyramidal tract neurons during skilled movements in the monkey. J. Neurosci. 1:453–460.
Fullerton, P. M. 1966. Chronic peripheral neuropathy produced by lead poisoning in guinea-pigs. J. Neuropathol. Exp. Neurol. 25:214–236.
Fullerton, P. M. 1969. Electrophysiological and histological observations on peripheral nerves in acrylamide poisoning in man. J. Neurol. Neurosurg. Psychiatry 32:186–192.
Gable, C. B. 1990. A compendium of public health data sources. Am. J. Epidemiology 131:381–393.
Gad, S. C. 1982. A neuromuscular screen for use in industrial toxicology. J. Toxicol. Environ. Health 9:691–704.
Gad, S. C., J. A. McKelvey, and R. A. Turney. 1979. NIAX Catalyst ESN: Subchronic neuropharmacology and neurotoxicology. Drug Chem. Toxicol. 2:223–236.
Gade, A., E. L. Mortensen, and P. Bruhn. 1988. "Chronic painter's syndrome": A reanalysis of psychological test data in a group of diagnosed cases, based on comparisons with matched controls. Acta Neurol. Scand. 77:293–306.
GAO (General Accounting Office). 1990a. Toxic Substances: EPA's Chemical Testing Program Has Made Little Progress. Report to the Chairman, Subcommittee on Environment, Energy, and Natural Resources, Committee on Government Operations, U.S. House of Representatives. GAO/RCED-90-112. U.S. General Accounting Office, Washington, D.C. April, 1990.
GAO (General Accounting Office). 1990b. Toxic Substances: Effectiveness of Unreasonable Risk Standards Unclear.
Report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, U.S. House of Representatives. GAO/RCED-90–189. U.S. General Accounting Office, Washington, D.C. July, 1990.
Gaylor, D. W. 1983. The use of safety factors for controlling risk. J. Toxicol. Environ. Health 11:329–336.
Gaylor, D. W., and W. Slikker, Jr. 1990. Risk assessment for neurotoxic effects. Neurotoxicology 11:211–218.
Genter, M. B., G. Szakál-Quin, C. W. Anderson, D. C. Anthony, and D. G. Graham. 1987. Evidence that pyrrole formation is a pathogenetic step in γ-diketone neuropathy. Toxicol. Appl. Pharmacol. 87:351–362.
Gerhart. K. M., J. S. Hong, and H. A. Tilson. 1985. Studies on the mechanism of chlordecone-induced tremor in rats. Neurotoxicology 2:765–787.
Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed. New York: Marcel Dekker. 494 pp.
Goetz, C. G. 1985. Pesticides and other environmental toxins. Pp. 107–131 in Neurotoxins in Clinical Practice. New York: Spectrum Publications, Inc.
Goldman, P. S. 1971. Functional development of the prefrontal cortex in early life and the problem of neuronal plasticity. Exp. Neurol. 32:366–387.
Goldman, R. H., and J. M. Peters. 1981. The occupational and environmental health history. JAMA 246:2831–2836.
Goldstein, A., and H. Kalant. 1990. Drug policy: Striking the right balance. Science 249:1513–1521.
Graham, D. G. 1980. Hexane neuropathy: A proposal for pathogenesis of a hazard of occupational exposure and inhalant abuse. Chem. Biol. Interact. 32:339–345.
Graham, D. I., S. U. Kim, N. K. Gonatas, and L. Guyotte. 1975. The neurotoxic effects of triethyltin (TET) sulfate on myelinating cultures of mouse spinal cord. J. Neuropath. Exp. Neurol. 34:401–412.
Graham, D. G., S. M. Tiffany, W. R. Bell, Jr., and W. F. Gutknecht. 1978. Autooxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds for C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14:644–653.
Graham, D. G., D. C. Anthony, K. Boelkelheide, N. A. Maschmann, R. G. Richards, J. W. Wolfram, and B. R. Shaw. 1982. Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking. Toxicol. Appl. Pharmacol. 64:415–422.
Griffin, J. W., and D. L. Price. 1980. Proximal axonopathies induced by toxic chemicals. Pp. 161–178 in Experimental and Clinical Neurotoxicology, P. S. Spencer and H. H. Schaumburg, eds. Baltimore, Md.: Williams & Wilkins .
Guzelian, P. S. 1982. Comparative toxicology of chlordecone (Kepone) in humans and experimental animals. Annu. Rev. Pharmacol. Toxicol. 22:89–113.
Haggerty, G. C. 1989. Development of Tier 1 neurobehavioral capabilities for incorporation into pivotal rodent safety assessment studies. J. Amer. Coll. Toxicol. 8:53–69.
Hammerschlag, R., and S. T. Brady. 1989. Axonal transport and the neuronal cytoskeleton. Pp. 457–478 in Basic Neurochemistry, 4th ed., G. Siegel, B. Agranoff, R. W. Albers, and P. Molinoff, eds. New York: Raven Press.
Hänninen, H., and K. Lindström. 1979. Behavioral Test Battery for Toxico-psychological Studies: Used at the Institute of Occupational Health in Helsinki, 2nd ed. Helsinki, Finland: Institute of Occupational Health.
Hattis, D., and K. Shapiro. 1990. Analysis of dose/time/response relationships for chronic toxic effects: The case of acrylamide. Neurotoxicology 11:219–236.
Heise, G. A. 1984. Behavioral methods for
measuring effects of drugs on learning and memory in animals. Med. Res. Rev. 4:535–558.
Herskowitz, A., N. Ishii, and H. Schaumburg. 1971. n-hexane neuropathy: A syndrome occurring as a result of industrial exposure. N. Engl. J. Med. 285:82–85.
Hertzman, C., M. Wiens, D. Bowering, B. Snow, and D. Calne. 1990. Parkinson's disease: A case-control study of occupational and environmental risk factors. Am J. Indust. Med. 17:349–355.
Hierons, R., and M. K. Johnson. 1978. Clinical and toxicological investigations of a case of delayed neuropathy in man after acute poisoning by an organophosphorus pesticide. Arch. Toxicol. 40:279–284.
Hill, R. M., and L. M. Tennyson. 1986. Maternal drug therapy: Effect on fetal and neonatal growth and neurobehavior. Neurotoxicology 7:121–140.
Hille, B. 1984. Ionic Channels of Excitable Membranes. Sunderland, Mass.: Sinauer Associates.
Hopkins, A. P., and Gilliatt, R. W. 1971. Motor sensory nerve conduction velocity in the baboon: Normal values and changes during acrylamide neuropathy. J. Neurol. Neurosurg. Psychiatry 34:415–426.
Horan, J. M., T. L. Kurt, P. J. Landrigan, J. M. Melius, and M. Singal. 1985. Neurologic dysfunction from exposure to 2-t-butylazo-2-hydroxy-5-methylhexane (BHMH): A new occupational neuropathy. Am. J. Pub. Health 75:513–517.
Hornykiewicz, O. 1986. Dopamine deficiency and dopamine substitution in Parkinson's disease. Pp. 319–330 in The Neurobiology of Dopamine Systems, W. Winlow and R. Markstein, eds. Manchester: Manchester University Press.
Hruska, R.E., S. Kennedy, and E.K. Silbergeld. 1979. Quantitative aspects of normal locomotion in rats. Life Sci. 25:171–179.
Hubel, D. H., and M. S. Livingstone. 1987. Segregation of form, color, and stereopsis in primate area 18. J. Neurosci. 7:3378–3415.
Hunter, D., and D. S. Russell. 1954. Focal cerebral and cerebellar atrophy in human subjects due to organic mercury compounds. J. Neurol. Neurosurg. Psychiatr. 17:235–241.
IOM (Institute of Medicine). 1991. Seafood Safety. Washington, D.C.: National Academy Press. 446 pp.
Irwin, S. 1968. Comprehensive observational assessment: Ia. A systematic quantitative procedure for assessing the behavioral and physiologic state of a mouse. Psychopharmacologia 13:222–257.
Isaacson, R. L., A. J. Nonneman, and L. W. Schmalz. 1968. Behavioral and anatomical sequelae of damage to the infant limbic system. Pp. 41–78 in The Neuropsychology of Development. New York: Wiley.
Jenner, P. 1989. Clues to the mechanism underlying dopamine cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. Special Supplement:22–28.
Johnson, B. L., ed. 1987. Prevention of Neurotoxic Illness in Working Populations. New York: John Wiley & Sons. 257 pp.
Johnson, B. L., and W. K. Anger. 1983. Behavioral toxicology. Pp. 329–350 in Environmental and Occupational Medicine, W. N. Rom, ed. Boston: Little, Brown and Company.
Johnson, D., K. Houghton, C. Siegel, J. Martyny, L. Cook, and E. J. Mangione. 1989. Occupational and paraoccupational exposure to lead. MMWR 38:338–340, 345. U.S. Department of Health and Human Services. Washington, D.C.: U.S. Government Printing Office.
Johnson, B. L., W. K. Anger, A. DuRao, and C. Xintaras, eds. 1990. Advances in Neurobehavioral Toxicology: Applications in Environmental and Occupational Health. Chelsea, Mich: Lewis Publishers, Inc.
Johnson, M. K. 1977. Improved assay of
neurotoxic esterase for screening organo-phosphates for delayed neurotoxicity potential. Arch. Toxicol. 37:113–115.
Jones, H. B., and J. B. Cavanagh. 1983. Distortions of the nodes of Ranvier from axonal distension by filamentous masses in hexacarbon intoxication. J. Neurocytol. 12:439–458.
Jones, K. L., and D. W. Smith. 1973. Recognition of the fetal alcohol syndrome in early infancy. Lancet 2:999–1001.
Katz, G. V., J. L. O'Donoghue, G. D. DiVincenzo, and C. J. Terhaar. 1980. Comparative neurotoxicity and metabolism of ethyl n-butyl ketone in rats. Toxicol. Appl. Pharmacol. 52:153–158.
Kellogg, C. K. 1985. Prenatal diazepam exposure in rats: Long-lasting functional changes in the offspring. Neurobehav. Toxicol. Teratol. 7:483–488.
Kelly, J. P. 1985. Reactions of neurons to injury. Pp. 187–195 in Principles of Neural Science, 2nd ed., E. R. Kandel and J. H. Schwartz, eds. New York: Elsevier Science Publishing Co., Inc.
Kim, S. U. 1971. Neurotoxic effects of alkyl mercury compound on myelinating cultures of mouse cerebellum. Exp. Neurol. 32:237–246.
Kimmel, C. A. 1990. Quantitative approaches to human risk assessment for noncancer health effects. Neurotoxicology 11:189–198.
Klaassen, C. D. 1986. Distribution, excretion, and absorption of toxicants. Pp. 33–63 in Casarett and Doull's Toxicology: The Basic Science of Poisons, 3rd ed., C. D. Klaassen, M. O. Amdur, and J. Doull, eds. New York: Plenum Press.
Kopin, I. J., and S. P. Markey. 1988. MPTP toxicity: Implications for research in Parkinson's disease. Annu. Rev. Neurosci. 11:81–96.
Korobkin, R., A. K. Asbury, A. J. Sumner, and S. L. Nielsen. 1975. Glue-sniffing neuropathy. Arch. Neurol. 32:158–162.
Krasavage, W. J., J. L. O'Donoghue, G. D. DiVincenzo, and C. J. Terhaar. 1980. The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. Toxicol. Appl. Pharmacol. 52:433–441.
Krewski, D., K. S. Crump, J. Farmer, D. W. Gaylor, R. Howe, C. Portier, D. Salsburg, R. L. Sielken, and J. van Ryzin. 1983. A comparison of statistical methods for low dose extrapolation utilizing time-to-tumor data. Fundam. Appl. Toxicol. 3:140–160.
Kulig, B.M. 1989. A neurofunctional test battery for evaluating the effects of long-term exposure to chemicals. J. Amer. Coll. Toxicol. 8:71–83.
Kurland, L. T. 1963. Epidemiological investigations of neurological disorders in the Mariana Islands. Pp. 219–223 in Epidemiology Reports on Research and Teaching, J. Pemberton, ed. New York: Oxford University Press.
Landrigan, P. J. 1989. Improving the surveillance of occupational disease. Am. J. Public Health 79:1601–1602.
Langston, J. W., and I. Irwin. 1986. MPTP: Current concepts and controversies. Clin. Neuropharmacol. 9:485–507.
Langston, J. W., P. Ballard, J. W. Tetrud, and I. Irwin. 1983. Chronic parkinsonism in humans due to a product of meper-idine-analog synthesis. Science 219:979–980.
Lave, L.B., and G.S. Omenn. 1986. Cost-effectiveness of short-term tests for car-cinogenicity. Nature 324:29–34.
Lawrence, L. J., and J. E. Casida. 1983. Stereospecific action of pyrethroid insecticides on the γ-aminobutyric acid receptor-ionophore complex. Science 221:1399–1401.
LeOuesne, P. M. 1980. Acrylamide. Pp. 309–325 in Clinical and Experimental Neurotoxicology, P. S. Spencer, and H. H. Schaumburg, eds. Baltimore: Williams & Wilkins.
LeQuesne, P. M. 1987. Clinically used electrophysiological end-points. Pp. 103–116 in Electrophysiology in Neurotoxicology, Vol. 1, H. E. Lowndes, ed.
Boca Raton, Fla.: CRC Press.
LeQuesne, P. M., and J. G. McLeod. 1977. Peripheral neuropathy following a single exposure to arsenic. Clinical course in four patients with electrophysiological and histological studies. J. Neurol. Sci. 32:437–451.
Letz, R. 1991. Use of computerized test batteries for quantifying neurobehavioral outcomes. Environ. Health Perspect. 90:195–198.
Letz, R., and E. L. Baker. 1986. Computer-administered neurobehavioral testing in occupational health. Sem. Occup. Med. 1:197–203.
Liebman, M. 1991. Neuroanatomy Made Easy and Understandable, 4th ed. Gaithersburg, Md.: Aspen Publishers, Inc.
Lilienfeld, D. E., E. Chan, J. Ehland, J. Godbold, P. J. Landrigan, G. Marsh, and D. P. Perl. 1989. Rising mortality from motoneuron disease in the USA, 1962–84. Lancet 1(8640):710–713.
Lim, D. J. 1986. Effects of noise and oto-toxic drugs at the cellular level in the cochlea: A review. Am. J. Otolaryngol. 7:73–99.
Little, R. E., K. W. Anderson, C. H. Ervin, B. Worthington-Roberts, and S. K. Clarren. 1989. Maternal alcohol use during breast-feeding and infant mental and motor development at one year. N. Engl. J. Med. 321:425–430.
Lowndes, H. E., and T. Baker. 1976. Studies on drug-induced neuropathies. III. Motor nerve deficit in cats with experimental acrylamide neuropathy. Eur. J. Pharmacol. 35:177–184.
Lowndes, H. E., T. Baker, E. S. Cho, and B. S. Jortner. 1978a. Position sensitivity of de-efferented muscle spindles in experimental acrylamide neuropathy. J. Pharmacol. Exp. Ther. 205:40–48.
Lowndes, H. E., T. Baker, L. P. Michelson, and M. Vincent-Ablazey. 1978b. Attenuated dynamic responses of primary endings of muscle spindles: A basis for depressed tendon responses in acrylamiden neuropathy. Ann. Nurol. 3:433–437.
Lund, A. E., and T. Narahashi. 1982. Dose-dependent interaction of the pyrethroid isomers with sodium channels of squid axon membranes. Neurotoxicol. 3:11–24.
Lund, A. E., and T. Narahashi. 1983. Kinetics of sodium channel modification as the basis for the variation in the nerve membrane effects of pyrethroids and DDT analogs. Pestic. Biochem. Physiol. 20:203–216.
MacMahon, B., and T. F. Pugh. 1970. Epidemiology: Principles and Methods. Boston: Little, Brown and Co. 376 pp.
MacPhail, R. C. 1985. Effects of pesticides on schedule-controlled behavior. Pp. 519–535 in Behavioral Pharmacology: The Current Status, L. S. Seiden and R. L. Balster, eds. New York: Alan R. Liss. 571 pp.
MacPhail, R. C., D. B. Peele, and K. M. Crofton. 1989. Motor activity and screening for neurotoxicity. J. Amer. Coll. Toxicol. 8:117–125.
Mailman, R. B. 1987. Mechanisms of CNS injury in behavioral dysfunction. Neurotoxicol. Teratol. 9:417–426.
Marsh, D. O., T. W. Clarkson, C. Cox, G. J. Myers, L. Amin-Zaki, and S. Al-Tikriti. 1987. Fetal methylmercury poisoning. Relationship between concentration in single strands of maternal hair and child effects. Arch. Neurol 44:1017–1022.
Martin-Bouyer, G., R. Lebreton, M. Toga, P. D. Stolley, and J. Lockhart. 1982. Outbreak of accidental hexachlorophene poisoning in France. Lancet 1(8263):91–95.
Marteniuk, G. 1976. Information Processing in Motor Skills. New York: Holt, Rinehart, and Winston. 244 pp.
Marwaha, J., and W. J. Anderson, eds. 1984. Neuroreceptors in Health and Disease. New York: Karger. 255 pp.
Matsumoto, H. G., D. Koya, and T. Takeuchi. 1965. Fetal Minamata disease: A neuropathological study of two cases of intrauterine intoxication by a methylmer-
cury compound. J. Neuropathol. Exp. Neurol. 24:563–574.
Mattsson, J. L., and R. R. Albee. 1988. Sensory evoked potentials in neurotoxicology. Neurotoxicol. Teratol. 10:435–443.
Mattson, J. L., R. R. Albee, and D. L. Eisenbrandt. 1989. Neurological approach to neurotoxicological evaluation in laboratory animals. J. Amer. Coll. Toxicol. 8:271–286.
Maurissen, J. P. J. 1988. Quantitative sensory assessment in toxicology and occupational medicine: Applications, theory, and critical appraisal. Toxicol. Lett. 43:321–343.
Maurissen, J. P. J., and J. L. Mattsson. 1989. Critical assessment of motor activity as a screen for neurotoxicity. Toxicol. Indust. Health 5:195–202.
Maurissen, J. P. J., B. Weiss, and H. T. Davis. 1983. Somatosensory thresholds in monkeys exposed to acrylamide. Toxicol. Appl. Pharmacol. 71:266–279.
McGeer, P. L., E. G. McGeer, and J. S. Suzuki. 1977. Aging and extrapyramidal function. Arch. Neurol. 34:33–35.
McKeown-Eyssen, G. E., J. Ruedy, and A. Neims. 1983. Methylmercury exposure in northern Quebec. II. Neurologic findings in children. Am. J. Epidem. 118:470–479.
Merigan, W. H., E. Barkdoll, and J. P. J. Maurissen. 1982. Acrylmide-induced visual impairment in primates. Toxicol. Appl. Pharmacol. 62:342–345.
Meyer, O. A., H. A. Tilson, W. C. Bryd, and M. T. Riley. 1979. A method for the routine assessment of fore-and hind-limb grip strength of rats and mice. Neurobehav. Toxicol. 1:233–236.
Miller, J. C., and A. J. Friedhoff. 1986. Prenatal neuroleptic exposure alters postnatal striatal cholinergic activity in the rat. Dev. Neurosci. 8:111–116.
Miller, M. S., and P. S. Spencer. 1985. The mechanisms of acrylamide axonopathy. Annu. Rev. Pharmacol. Toxicol. 25:643–666.
Milnor, W. R. 1968. Blood supply of special regions. Pp. 221–243 in Medical Physiology, Vol. I, 12th ed., V. B. Mount-castle, ed. St. Louis: C. V. Mosby.
Misumi, J., and M. Nagano. 1984. Neurophysiological studies on the relation between the structural properties and neurotoxicity of aliphatic hydrocarbon compounds in rats. Br. J. Ind. Med. 41:526–532.
MMWR (Morbidity and Mortality Weekly Report). 1986. Aldicarb food poisoning from contaminated melons—California. JAMA 256:175–176.
Moore, R. W., C. R. Jefcoate, and R. E. Peterson. 1991. 2,3,7,8-Tetrachlorodiben-zo-p-dioxin inhibits steroidogenesis in the rat testis by inhibiting the mobilization of cholesterol to cytochrome P450scc. Toxicol. Appl. Pharmacol. 109:85–97.
Moser, V. C. 1989. Screening approaches to neurotoxicity: A functional observational battery. J. Amer. Coll. Toxicol. 8:85–94.
Moser, V. C., J. P. McCormick, J. P. Creason, and R. C. MacPhail. 1988. Comparison of chlordimeform and carbaryl using a functional observational battery. Fundam. Appl. Toxicol. 11:189–206.
Murai, Y., S. Shiraishi, Y. Yamashita, A. Ohnishi, and K. Arimura. 1982. Neurophysiological effects of methylmercury on the nervous system. Electroencephalog. Clin. Neurophysiol. Suppl. 36:682–687.
Narahashi, T. 1971. Effects of insecticides on excitable tissues. Pp. 1–93 in Advances in Insect Physiology, Vol. 8, J. W. L. Beament, J. E. Treherne, and V. B. Wigglesworth, eds. London and New York: Academic Press.
Narahashi, T. 1985. Nerve membrane ionic channels as the primary target of pyrethroids. Neurotoxicology 6:3–22.
Narahashi, T. 1989. The role of ion channels in insecticides. Pp. 55–84 in Insecticide Action: From Molecule to Organism, T. Narahashi and J. E. Chambers, eds. New York: Plenum Press.
Narahashi, T., and J. M. Frey. 1989. Lindane and cyclodiene insecticides block GABA-activated chloride current in cultured rat hippocampal neurons. Paper presented at the 19th annual meeting of the Society for Neuroscience, Phoenix, Ariz. 29 October—3 November.
Narahashi, T., and A. E. Lund. 1980. Giant axons as models for the study of the mechanism of action of insecticides. Pp. 497–505 in Insect Neurobiology and Pesticide Action (Neurotox 79). Proceedings of a Society of Chemical Industry Symposium, York, England, 3–7 September, 1979. London: Society of Chemical Industry.
National Conference on Clustering of Health Events. 1990. Am. J. Epidem. 132(1):Supple.
NCCLS (National Committee for Clinical Laboratory Standards). 1981. List of Standards. Villanova, Penn.: National Committee for Clinical Laboratory Standards.
NCCLS (National Committee for Clinical Laboratory Standards). 1985. List of Standards. Villanova, Penn.: National Committee for Clinical Laboratory Standards.
NCHS (National Center for Health Statistics). 1984. Blood lead levels for persons age 6 months-74 years: United States, 1976–80. Data from the National Health and Nutrition Examination Survey. Vital and Health Statistics, Series 11, No. 233. DHHS Pub. No. (PHS) 84-1683. Public Health Service, Washington, D.C.: U.S. Government Printing Office.
Needleman, H. L. 1986. Epidemiological studies. Pp. 279–287 in Neurobehavioral Toxicology, Z. Annau, ed. Baltimore: The Johns Hopkins University Press.
Needleman, H. L. 1989. The persistent threat of lead: A singular opportunity. Commentaries in Am. J. Pub. Health 79:643–645.
Needleman, H. L., and C. A. Gatsonis. 1990. Low-level lead exposure and the IQ of children: A meta-analysis of modern studies. JAMA 263:673–678.
Newland, M. C. 1988. Quantification of motor function in toxicology. Toxicol. Lett. 43:295–319. Elsevier Science Publishers.
NIEHS (National Institute for Environmental Health Sciences), Task Force 3. 1985. Biochemical and Cellular Markers of Chemical Exposure and Preclinical Indicators of Disease. Washington, D.C.: U.S. Department of Health and Human Services.
NIOSH (National Institute for Occupational Safety and Health). 1977. National Occupational Hazard Survey, Vol. 3, Survey Analysis and Supplemental Tables. USDHEW (NIOSH) Pub. No. 78–114. Cincinnati, Ohio: NIOSH Publications Office.
NIOSH (National Institute for Occupational Safety and Health). 1986. Leading work-related diseases and injuries-United States. MMWR 35:113–116, 121–123.
NRC (National Research Council). 1977. Principles and Procedures for Evaluating the Toxicity of Household Substances. Washington, D.C.: National Academy Press. 140 pp.
NRC (National Research Council). 1983. Risk Assessment in the Federal Government: Managing the Process. Washington D.C.: National Academy Press. 191 pp.
NRC (National Research Council). 1984. Toxicity Testing: Strategies to Determine Needs and Priorities. Washington D.C.: National Academy Press. 382 pp.
NRC (National Research Council). 1986. Drinking Water and Health. Vol. 6. Washington D.C.: National Academy Press. 457 pp.
NRC (National Research Council). 1987a. Counting Injuries and Illnesses in the Workplace. Washington, D.C.: National Academy Press. 176 pp.
NRC (National Research Council). 1987b. Drinking Water and Health. Vol. 8,
Pharmacokinetics, in Risk Assessment. Washington, D.C.:National Academy Press. 488 pp.
NRC (National Research Council). 1989a. Biologic Markers in Pulmonary Toxicology. Washington, D.C.:National Academy Press. 179 pp.
NRC (National Research Council). 1989b. Biologic Markers in Reproductive Toxicology. Washington, D.C.:National Academy Press. 395 pp.
NRC (National Research Council). 1990. Health Effects of Exposure to Low Levels of Ionizing Radiation (BIER 5). Washington, D.C.:National Academy Press. 433 pp.
NRC (National Research Council). 1991a. Biological Markers of Immunotoxicology. Washington, D.C.:National Academy Press. (In press.)
NRC (National Research Council). 1991b. Monitoring Human Tissues for Toxic Substances. Washington, D.C.:National Academy Press. 211 pp.
Nriagu, J. O. 1978. Properties and the biogeochemical cycle of lead. Pp. 1–4 in the Biogeochemistry of Lead in the Environment, Part A, J. J. Nriagu, ed. Amsterdam:Elsevier/North Holland Biomedical Press.
O'Callaghan, J. P. 1988. Neurotypic and gliotypic proteins as biochemical markers of neurotoxicity. Neurotoxicol. Teratol. 10:445–452. New York, N.Y.:Pergamon Press.
O'Donoghue, J. L. 1986. Neurotoxic Risk Assessment in Industry. Paper presented at the annual meeting of the American Association for the Advancement of Science symposium Evaluating Neurotoxic Risk Posed in the Workplace and Environment, Philadelphia, Pa., May 26.
O'Donoghue, J. L. 1989. Screening for neurotoxicity using a neurologically based examination and neuropathology. J. Amer. Coll. Toxicol 8:97–115.
Ogata, N., S. M. Vogel, and T. Narahashi. 1988. Lindane but not deltamethrin blocks a component of GABA-activated chloride channels. Fed. Am. Soc. Exp. Biol. J. (FASEB) 2:2895–2900.
Omenn, G. S. 1986. Susceptibility to occupational and environmental exposure to chemicals. Prog. Clin. Biol. Res. 214:527–545.
OTA (Office of Technology Assessment), U.S. Congress. 1984. Impacts of Neuroscience: A Background Paper. OTA-BP—BA-24. Washington, D.C.: U.S. Government Printing Office.
OTA (Office of Technology Assessment), U.S. Congress. 1987. Identifying and Regulating Carcinogens. OTA-BP-H-42. Washington, D.C.: U.S. Government Printing Office.
OTA (Office of Technology Assessment), U.S. Congress. 1990. Neurotoxicity: Identifying and Controlling Poisons of the Nervous System, OTA-BA-436. Washington, D.C.: U.S. Government Printing Office.
Otake, M., and W. J. Schull. 1984. In utero exposure to A-bomb radiation and mental retardation: A reassessment. Br. J. Radiol. 57:409–414.
Otto, D., and D. Eckerman, eds. 1985. Workshop on neurotoxicity testing in human populations: Workshop overview. Neurobehav. Toxicol. Teratol. 7:283–418.
Overstreet, D. H. 1977. Pharmacological approaches to habituation of the acoustic startle response in rats. Physiol. Psychol. 5:230–238.
Pardridge, W. M. 1988. Recent advances in blood-brain barrier transport. Annu. Rev. Pharmacol. Toxicol. 28:25–39.
Parkinson, D. K., E. J. Bromet, S. Cohen, L. O. Dunn, M. A. Dew, C. Ryan, and J. E. Schwartz. 1990. Health effects of long-term solvent exposure among women in blue-collar occupations. Am. J. Ind. Med. 17:661–675.
Pearson, D. T, and K. N. Dietrich. 1985. The behavioral toxicology and teratology of childhood: Models, methods, and implications for intervention. Neurotoxi-
cology 6:165–182.
Peele, D. B. 1989. Learning and memory: Considerations for toxicology. J. Amer. Coll. Toxicol. 8:213–224.
Perl, T. M., L. Bedard, T. Kosatsky, J. C. Hockin, E. D. C. Todd, and R. S. Remis. 1990. An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid. N. Engl. J. Med. 322:1775–1780.
Pestronk, A., J. P. Keogh, and J. W. Griffin. 1979. Dimethylaminopropionitrile (DMAPN) intoxication: A new industrial neuropathy. Neurology 29:540.
Peto, R., M. C. Pike, N. E. Day, R. G. Gray, P. N. Lee, S. Parish, J. Peto, S. Richards, and J. Wahrendorf. 1980. Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. Monographs on the Long-term and Short-term Screening Assays for Carcinogens: A Critical Appraisal. International Agency for Research Against Cancer (IARC). Supplement 2:311–426. Geneva: World Health Organization.
Pierce, P. E., J. F. Thompson, W. H. Likosky, L. N. Nickey, W. F. Barthel, and A. R. Hinman. 1972. Alkyl mercury poisoning in humans. Report of an outbreak. JAMA 220:1439–1442.
Politis, M. J., H. H. Schaumburg, and P. S. Spencer. 1980. Neurotoxicity of selected chemicals. P. 619 in Experimental and Clinical Neurotoxicology, P. S. Spencer and H. H. Schaumburg, eds. Baltimore: Williams & Wilkins.
Provenzano, G. 1980. The social costs of excessive lead exposure during childhood. Pp. 199–315 in Low Level Lead Exposure, H. L. Needleman, ed. New York: Raven Press.
Pryor, G. T., J. Dickinson, R. A. Howd, and C. S. Rebert. 1983. Transient cognitive deficits and high-frequency hearing loss in weanling rats exposed to toluene. Neurobehav. Toxicol. Teratol. 5:53–57.
Rakic, P., and K. P. Riley. 1983. Overproduction and elimination of retinal axons in the fetal rhesus monkey. Science 219:1441–1444.
Rebert, C. S., S. S. Sorenson, R. A. Howd, and G. T. Pryor. 1983. Toluene-induced hearing loss in rats evidenced by the brainstem auditory-evoked response. Neurobehav. Toxicol. Teratol. 5:59–62.
Reiter, L. W. 1980. Neurotoxicology—meet the real world [editorial]. Neurobehav. Toxicol. 2:73–74.
Reiter, L. W. 1987. Neurotoxicology in regulation and risk assessment. Dev. Pharmacol. Ther. 10:354–368.
Reiter, L. W., and R. C. MacPhail. 1979. Motor activity: A survey of methods with potential use in toxicity testing. Neurobehav. Toxicol. 1(Suppl. 1):53–66.
Rice, D. C. 1988. Quantification of operant behavior. Toxicol. Lett. 43:361–379.
Rice, D. P., T. A. Hodgson, and A. N. Kopstein. 1985. The economic costs of illness: A replication and update. Health Care Financing Review 7:68–69. U.S. Department of Health and Human Services, Health Care Financing Administration, Baltimore, Md.
Riley, A. L., and D. L. Tuck. 1985. Conditioned taste aversions: A behavioral index of toxicity. Ann. N.Y. Acad. Sci. 443:272–292.
Rodier, P. M. 1986. Time of exposure and time of testing in developmental neurotoxicology. Neurotoxicology 7:69–76.
Rodier, P. M., W. S. Webster, and J. Langman. 1975. Morphological and behavioral consequences of chemically-induced lesions of the CNS . Pp. 169–176 in Aberrant Development of Human Infancy: Human and Animal Studies, N. Ellis, ed. New York: Erlbaum Press.
Rodier, P. M., B. Kates, W. A. White, and A. Muhs. 1991. Effects of prenatal exposure to methylazoxymethanol (MAM) on brain weight, hypothalamic cell number, pituitary structure, and postnatal growth in the rat. Teratol ogy 43:241–251.
Ronnett, G. V., L. D. Hester, J. S. Nye, K.
Connors, and S. H. Snyder. 1990. Human cortical neuronal cell line: Establishment from a patient with unilateral megalencephaly. Science 248:603–605.
Rosenberg, C. K., M. B. Genter, G. Szakál-Quin, D. C. Anthony, and D. G. Graham. 1987. dl-versus meso-3,4-dimethyl-2,5-hexanedione: A morphometric study of the proximo-distal distribution of axonal swellings in the anterior root of the rat. Toxicol. Appl. Pharmacol. 87:363–373.
Rosengarten, H., and A. J. Friedhoff. 1979. Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. Science 203:1133–1135.
Rosner, D., and G. Markowitz. 1985. A ''gift of God''?: The public health controversy over leaded gasoline during the 1920s. Am. J. Public Health 75:344–52.
Ruigt, G. S. F. 1984. Pyrethroids. Ch. 7 in Comprehensive Insect Physiology, Biochemistry and Pharmacology, Vol. 12, G. A. Kerkut and L. I. Gilbert, eds. Oxford: Pergamon Press.
Rutstein, D. D., W. Berenberg, T. C. Chalmers, A. P. Fishman, and E. B. Perrin. 1976. Measuring the quality of medical care: A clinical method. N. Engl. J. Med. 294:582–588.
Rutstein, D. D., R. J. Mullan, T. M. Frazier, W. E. Halperin, J. M. Melius, and J. P. Sestito. 1983. Sentinel health events (occupational): A basis for physician recognition and public health surveillance. Am. J. Public Health 73:1054–1062.
Sager, P. R., M. Aschner, and P. M. Rodier. 1984. Persistent, differential alterations in developing cerebellar cortex of male and female mice after methylmercury exposure. Dev. Brain Res. 12:1–11.
Sayre, L. M., L. Autilio-Gambetti, and P. Gambetti. 1985. Pathogenesis of experimental giant neurofilamentous axonopathies: A unified hypothesis based on chemical modification of neurofilaments. Brain Res. Rev. 10:69–83.
Sayre, L. M., C. M. Shearson, T. Wongmongkolrit, R. Medori, and P. Gambetti. 1986. Structural basis of γ-diketone neurotoxicity: Non-neurotoxicity of 3,3dimethyl-2,5-hexanedione, a γ-diketone incapable of pyrrole formation. Toxicol. Appl. Pharmacol. 84:36–44.
Schaumburg, H. H., and P. S. Spencer. 1976. Degeneration in central and peripheral nervous systems produced by pure n-hexane: An experimental study. Brain 99:183–192.
Schrot, J., J. R. Thomas, and R. A. Banvard. 1980. Modification of the repeated acquisition of response sequences in rats by low-level microwave exposure. Bioelectromagnetics 1:89–99.
Schrot, J., J. R. Thomas, and R. F. Robertson. 1984. Temporal changes in repeated acquisition behavior after carbon monoxide exposure. Neurobebav. Toxicol. Teratol. 6:23–28.
Schull, W. J., S. Norton, and R. P. Jensh. 1990. Ionizing radiation and the developing brain. Neurotoxicol. Teratol. 12:249–260.
Schwartz, J. H. 1985. Molecular aspects of post-synaptic receptors. Pp. 159–175 in Principles of Neural Science, E. R. Kandel and J. H. Schwartz, eds. New York: Elsevier.
Schwartz, J., C. Angle, and H. Pitcher. 1986. Relationship between childhood blood lead levels and stature. Pediatrics 77:281–286.
Schwartz, J., P. J. Landrigan, R. G. Feldman, E. K. Silbergeld, E. L. Baker, and I. H. Von Lindern. 1988. Threshold effect in lead-induced peripheral neuropathy. J. Pediatr. 112:12–17.
Seil, F. J., P. W. Lampert, and I. Klatzo. 1969. Neurofibrillary spheroids induced by aluminum phosphate in dorsal root ganglia neurons in vitro. J. Neuropathol. Exp. Neurol. 28:74–85.
Seppalainen, A. M. H., and M. Haltia. 1980. Carbon disulfide. Pp. 356–373 in Experimental and Clinical Neurotoxicology, P. S. Spencer and H. H. Schaumburg, eds.
Baltimore: Williams & Wilkins.
Sette, W. F. 1987. Complexity of neurotoxicological assessment. Neurotoxicol. Teratol. 9:411–416.
Shalat, S. L., B. Seltzer, and E. L. Baker, Jr. 1988. Occupational risk factors and Alzheimer's disease: A case-control study. J. Occup. Med. 12:934–6.
Shepard, T. H. 1989. A Catalog of Teratogenic Agents, 6th ed. Baltimore, Md.: Johns Hopkins University Press.
Shiraishi, S., N. Inoue, Y. Murai, A. Onishi, and S. Noda. 1983. Dipterex (trichlorfon) poisoning: Clinical and pathological studies in human and monkeys. Sangyo Ika Daigaku Zasshi. 5(Suppl.):125–132.
Silbergeld, E. K. 1986. Maternally mediated exposure of the fetus: In utero exposure to lead and other toxins. Neurotoxicology 7:557–568.
Silbergeld, E. 1990. Developing formal risk assessment methods for neurotoxicants: An evaluation of the state of the art. Pp. 133–148 in Advances in Neurobehavioral Toxicology: Applications in Environmental and Occupational Health, B. L. Johnson, W. K. Anger, A. Durao, and C. Xintaras, eds. Chelsea, Mich.: Lewis Publishers, Inc.
Silbergeld, E. K., and J. J. Chisolm. 1976. Lead poisoning: Altered urinary catecholamine metabolites as indicators of intoxication in mice and children. Science 192:153–155.
Silbergeld, E. K., and R. E. Hruska. 1980. Neurochemical investigations of low level lead exposure. Pp. 135–157 in Low Level Lead Exposure: The Clinical Implications of Current Research, H. L. Needleman, ed. New York: Raven Press.
Smith, H. V., and J. M. K. Spaulding. 1959. Outbreak of paralysis in Morocco due to orthocresyl phosphate poisoning. Lancet 2:1019.
Smith, M. I., E. Elvove, P. J. Valaer, Jr., W. H. Frazier, and G. E. Mallory. 1930. Pharmacological and chemical studies of the cause of so-called ginger paralysis. U.S. Public Health Reports 45:1703–1716.
Smith, M. A., L. D. Grant, A. I. Sors, eds. 1989. Lead Exposure and Child Development: An International Assessment. Dorcrecht, the Netherlands: Kluwer Academic Publishers.
Sobotka, T. J. 1986. The regulatory perspective of diet-behavior relationships. Nutr. Rev. 44:241–245.
Sokoloff, L. 1989. Circulation and energy metabolism of the brain. Pp. 565–590 in Basic Neurochemistry, 4th ed., G. Siegel, B. Agranoff, R. Albers, and P. Molinoff, eds. New York: Raven Press.
Spencer, P. S., and H. H. Schaumburg. 1977a. Ultrastructural studies of the dying-back process, III. The evolution of experimental peripheral giant axonal degeneration. J. Neuropathol. Exp. Neurol. 36:276–299.
Spencer, P. S., and H. H. Schaumburg. 1977b. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies. J. Neuropathol. Exp. Neurol. 36:300–320.
Spencer, P. S., and H. H. Schaumburg, eds. 1980. Experimental and Clinical Neurotoxicology. Baltimore: Williams & Wilkins.
Spencer P. S., H. H. Schaumburg, R. L. Raleigh, and C. J. Terhaar. 1975. Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone. Arch. Neurol. 32:219–222.
Spencer, P. S., M. C. Bischoff, and H. H. Schaumburg. 1978. On the specific molecular configuration of neurotoxic aliphatic hexacarbon compounds causing central-peripheral distal axonopathy. Toxicol. Appl. Pharmacol. 44:17–28.
Spencer, P. S., M. I. Sabri, H. H. Schaumburg, and C. L. Moore. 1979. Does a defect of energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies? Ann. Neurol. 5:501–507.
Spencer, P. S., M. C. Bischoff, and H. H. Schaumburg. 1980. Neuropathological methods for the detection of neurotoxic disease. Pp. 743–757 in Experimental and Clinical Neurotoxicology, P. S. Spencer and H. H. Schaumburg, eds. Baltimore, Md.: Williams & Wilkins.
Spencer, P. S., J. Arezzo, and H. Schaumburg. 1985. Chemicals causing disease of neurons and their processes. Pp. 1–14 in Neurotoxicity of Industrial and Commercial Chemicals, Vol. 1, J. L. O'Donoghue, ed. Boca Raton, Fla.: CRC Press.
Spencer, P. S., P. B. Nunn, J. Hugon, A. C. Ludolph, S. M. Ross, D. N. Roy, and R. C. Robertson. 1987. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin . Science 237:517–522.
Spyker, J. M. 1975. Assessing the impact of Iow level chemicals on development: Behavioral and latent effects. Fed. Proc. 34:1835–1844.
Srivastava, A. K., M. Das, and S. K. Khanna. 1990. An outbreak of tricresyl phosphate poisoning in Calcutta, India. F. Chem. Toxic. 28:303–304.
St. Clair, M. B. Genter, V. Amarnath, M. A. Moody, D. C. Anthony, C. W. Anderson, and D. G. Graham. 1988. Pyrtole oxidation and protein crosslinking as necessary steps in the development of γ-diketone neuropathy. Chem. Res. Toxicol. 1:179–185.
St. Clair, M. B. Genter, D. C. Anthony, C. J. Wikstrand, and D. G. Graham. 1989. Neurofilament protein in γ-diketone neuropathy: In vitro and in vivo studies using the seaworm Myxicola infundibulum. Neurotoxicology 10:743–756
Stark, M., T. Bilzer, N. Inoue, and W. Wechsler. 1989. Influence of 5-azacytidine on differentiation and growth in rat nervous system tumor cell lines. Neurotoxicol. Teratol. 11:557–561.
Stebbins, W. C., D. B. Moody, J. E. Hawkins, Jr., L. G. Johnsson, and M. A. Norat. 1987. The species-specific nature of the ototoxicity of dihydrostreptomycin in the patas monkey. Neurotoxicology 8:33–44.
Sterman, A. B., and H. H. Schaumburg. 1980. Neurotoxicity of selected drugs. Pp. 593–612 in Experimental and Clinical Neurotoxicology, P. S. Spencer and H. H. Schaumburg, eds. Baltimore, Md.: Williams & Wilkins.
Streissguth, A. P., H. M. Barr, P. D. Sampson, B. L. Darby, and D. C. Martin. 1989. IQ at age 4 in relation to maternal alcohol use and smoking during pregnancy. Dev. Psychol. 25:3–11.
Stryer, L. 1983. Transducin and the cyclic GMP phosphodiesterase: Amplifier protein in vision. Cold Spring Harbor Symposium. Quant. Biol. 48, Pt. 2:841–852.
Swygert, L. A., E. F. Maes, L. E. Sewell, L. Miller, H. Falk, and E. M. Kilbourne. 1990. Eosinophilia-myalgia syndrome. Results of a national surveillance . JAMA 264:1698–1703.
Szakál-Quin, G., D. G. Graham, D. S. Millington, D. A. Maltby, and A. T. McPhail. 1986. Stereoisomer effects on the Paul-Knorr synthesis of pyrroles. J. Org. Chem. 51:621–624.
Takahashi, M., T. Ohara, and K. Hashimoto. 1971. Electrophysiological study of nerve injuries in workers handling acrylamide. Int. Arch. Arbeitsmed. 28:1–11.
Takeuchi, T. 1977. Pathology of fetal Minamata disease: Effect of methylmercury on human intrauterine life. Paediatrician 6:69–87.
Teitelbaum, J. S., R. J. Zatorre, S. Carpenter, D. Gendron, A. C. Evans, A. Gjedde, and N. R. Cashman. 1990. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N. Engl. J. Med. 322:1781–1787.
Tilson, H. A. 1987. Behavioral indices of neurotoxicity: What can be measured? Neurotoxicol. Teratol. 9:427–443.
Tilson, H. A. 1990a. Animal neurobehavioral test battery in NTP assessment.
Pp. 403–418 in Advances in Neurobehavioral Toxicology: Applications in Environmental and Occupational Health, B. L. Johnson, W. K. Anger, A. DuRao, and C. Xintaras, eds. Chelsea, Mich.: Lewis Publishers, Inc.
Tilson, H. A. 1990b. Neurotoxicology in the 1990s. Neurotoxicol. Teratol. 12:293–300.
Tilson, H. A., and C. L. Mitchell. 1984. Neurobehavioral techniques to assess the effects of chemicals on the nervous system. Annu. Rev. Pharmacol. Toxicol. 24:425–450.
Towfighi, J., N. K. Gonatas, and L. McCree. 1974. Hexachlorophene neuropathy in rats. Lab. Invest. 31:712–21.
U.S. House of Representatives, Committee on Science and Technology. 99th Congress, Second Session. 1986. Neurotoxins: At Home and the Workplace. Report 99-827. Washington, D.C.: U.S. Government Printing Office.
Vasilescu, C. 1976. Sensory and motor conduction in chronic carbon disulphide poisoning. Eur. Neurol. 14:447–457.
Verity, M. A., T. S. Sarafian, W. Guerra, A. Ettinger, and J. Sharp. 1990. Ionic modulation of triethyllead neurotoxicity in cerebellar granule cell culture. Neurotoxicol. 11:415–426.
Veronesi, B., E. R. Peterson, G. DiVincenzo, and P. S. Spencer. 1978. A tissue culture model of distal (dying-back) axonopathy: Its use in determining primary neurotoxic hexacarbon compounds. J. Neuropath. Exp. Neurol. 33:703(Abs).
Vigliani, E. C. 1954. Carbon disulfide poisoning in viscose rayon workers. Br. J. Industr. Med. 11:325–344.
Vorhees, C. V. 1986. Comparison and critique of government regulations for behavioral teratology. In Handbook of Behavioral Teratology, E. P. Riley and C. V. Vorhees, eds. New York: Plenum Press.
Wagener, Diane K., and P. A. Buffler. 1989. Geographic distribution of deaths due to sentinel health event (occupational) causes. Am. J. Indnst. Med. 16:355–372.
Waldron, H. A. 1973. Lead poisoning in the ancient world. Med. Hist. (London) 17:391–399.
Walker, C. H., W. O. Faustman, S. C. Fowler, and D. B. Kazar. 1981. A multi-variate analysis of some operant variables used in behavioral pharmacology. Psychopharmacology (Berlin) 74:182–186.
Wallace, R. B., C. E. DanieLs, J. Altman. 1972. Behavioral effects of neonatal irradiation of the cerebellum. 3. Qualitative observations in aged rats. Dev. Psychobiol. 5:35–41.
Weiss, B. 1990. Risk assessment: The insidious nature of neurotoxicity and the aging brain. Neurotoxicology 11:305–313.
Weiss, B., and T. W. Clarkson. 1986. Toxic chemical disasters and the implications of Bhopal for technology transfer. Milbank Q. 64:216–240.
West, J. R. 1990. Reply to: Response to letters dealing with warning labels on alcoholic beverages. Teratology 41:485–487.
WHO (World Health Organization). 1986. Principles and Methods for the Assessment of Neurotoxicity Associated with Exposure to Chemicals. Environmental Health Criteria Document 60. Geneva: World Health Organization.
Williamson, A. M. 1990. The development of a neurobehavioral test battery for use in hazard evaluations in occupational settings. Neurotoxicol. Teratol. 12:509–514.
Williamson, A. M., and R. K. C. Teo. 1986. Neurobehavioral effects of occupational exposure to lead. Brit. J. Indus. Med. 43:374–380.
Williamson, A. M., R. K. C. Teo, and J. Sanderson. 1982. Occupational mercury exposure and its consequences for behavior. Int. Arch. Occup. Environ. Health. 50:273–286.
Willis, W. D., Jr., and R. G. Grossman. 1973. P. 62 in Medical Neurobiology: Neuroanatomical and Neurophysiological
Principles Basic to Clinical Neuroscience. St. Louis: C. V. Mosby.
Winder, C., and I. Kitchen. 1984. Lead neurotoxicity: A review of the biochemical, neurochemical, and drug-induced behavioural evidence. Prog. Neurobiol. 22:59–87.
Wouters, W., and J. van den Bercken. 1978. Action of pyrethroids. Gen. Pharmacol. 9:387–398.
Wyzga, R. 1990. Towards quantitative risk assessment for neurotoxicity. Neurotoxicology 11:199–208.
Yamamoto, D., F. N. Quandt, and T. Narahashi. 1983. Modification of single sodium channels by the insecticide tetramethrin. Brain Res. 274:344–349.
Yamamura, Y. 1969. n-Hexane polyneuropathy. Folia Psychiatr. Neurol. Jpn. 23:45–57.
Yokel, R. A. 1983. Repeated systemic aluminum exposure effects on classical-conditioning of the rabbit. Neurobehav. Toxicol. Teratol. 5:41–46.
Yokel, R. A., S. D. Provan, J. J. Meyer, and S. R. Campbell. 1988. Aluminum intoxication and the victim of Alzheimer's disease: Similarities and differences. Neurotoxiciology 9:429–442.
Zec, R. F., and D. R. Weinberger. 1986. Relationship between CT scan findings and neuropsychological performance in chronic schizophrenia. Psychiat. Clin. North Am. 9:49–61.
Zeisler, R., S. H. Harrison, and S. A. Wise, eds. 1983. The Pilot National Environmental Specimen Bank: Analysis of Human Liver. National Bureau of Standards Special Publication 656. National Bureau of Standards, U.S. Department of Commerce, Washington, D.C. 128 pp.
